Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide: a remarkable comeback.

J M Jacobson1

  • 1Department of Medicine, Mount Sinai Medical School, Box 1009-1 Gustave Levy Place, New York, NY 10029, USA. Jeffrey.jacobson@mssm.edu

Expert Opinion on Pharmacotherapy
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era.

AIDS care·2023
Same author

HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

Journal of viral hepatitis·2017
Same author

Assessing risk of a short-term antiretroviral therapy discontinuation as a read-out of viral control in immune-based therapy.

Journal of medical virology·2012
Same author

Femtosecond transillumination optical coherence tomography.

Optics letters·2009
Same author

Femtosecond pulse generation in a Ti:A1(2)O(3) laser by using second- and third-order intracavity dispersion.

Optics letters·2009
Same author

Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.

AIDS (London, England)·2001
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Thalidomide, a drug withdrawn due to birth defects, shows new promise for treating inflammatory conditions like erythema nodosum leprosum and HIV-related ulcers due to its immunomodulatory effects.

Area of Science:

  • Pharmacology
  • Immunology
  • Teratology

Background:

  • Thalidomide, a synthetic glutamic acid derivative, was withdrawn globally due to severe teratogenicity.
  • Recent research highlights thalidomide's immunomodulatory and anti-angiogenic properties, prompting renewed scientific interest.

Purpose of the Study:

  • To review the current understanding of thalidomide's therapeutic applications and adverse effects.
  • To investigate the immunologic mechanisms underlying thalidomide's efficacy.

Main Methods:

  • Review of controlled clinical trials and preliminary studies.
  • Analysis of pharmacokinetic and metabolic pathways.
  • Assessment of adverse event profiles.

Main Results:

Related Experiment Videos

  • Thalidomide demonstrated efficacy in treating erythema nodosum leprosum, HIV-associated aphthous ulcers, and Behcet's syndrome.
  • Preliminary studies suggest potential in other immunologic and neoplastic disorders.
  • Adverse effects include teratogenicity, peripheral neuropathy, and sedation.

Conclusions:

  • Thalidomide is an orally bioavailable drug with established efficacy for specific inflammatory conditions.
  • Its immunomodulatory effects warrant further investigation for broader therapeutic applications.
  • Strict prescribing protocols are necessary due to its teratogenic potential.